Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Isolated Growth Hormone Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01088399
What this trial is testing

A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults

Who this might be right for
HypopituitarismPituitary InsufficiencyGrowth Hormone Deficiency, Adult
Eli Lilly and Company 10,673
Not applicableStudy completedNCT00934063
What this trial is testing

An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone Deficiency
Novo Nordisk A/S 121
Not applicableStudy completedNCT01947894
What this trial is testing

A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients

Who this might be right for
Growth Hormone Deficiency
Pfizer 377
Not applicableEnded earlyNCT00263445
What this trial is testing

Constructing an Insulin-Like Growth Factor-based Prediction Model

Who this might be right for
Growth Hormone DeficiencyIdiopathic Short StatureSmall for Gestational Age
University of California, Los Angeles 30
Early research (Phase 1)Study completedNCT00931476
What this trial is testing

A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone DeficiencyHealthy
Novo Nordisk A/S 86
Testing effectiveness (Phase 2)Ended earlyNCT00308464
What this trial is testing

Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Pfizer 136
Not applicableStudy completedNCT01120977
What this trial is testing

Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study

Who this might be right for
Growth Hormone Deficiency
University of Aarhus 150
Not applicableStudy completedNCT00960128
What this trial is testing

Observational Prospective Study on Patients Treated With Norditropin®

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenAdult Growth Hormone Deficiency+7 more
Novo Nordisk A/S 21,249
Not applicableStudy completedNCT01306357
What this trial is testing

Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device

Who this might be right for
Turner's SyndromeHuman Growth Hormone Deficiency
Ferring Pharmaceuticals 87
Not applicableStudy completedNCT00324064
What this trial is testing

Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing

Who this might be right for
Growth Hormone Deficiency
Children's Mercy Hospital Kansas City 90
Testing effectiveness (Phase 2)Ended earlyNCT00314938
What this trial is testing

A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Pfizer 32
Post-approval studies (Phase 4)UnknownNCT03290235
What this trial is testing

Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children

Who this might be right for
Growth Retardation
Changchun GeneScience Pharmaceutical Co., Ltd. 1,500
Large-scale testing (Phase 3)Study completedNCT00553852
What this trial is testing

Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity

Who this might be right for
ObesityGHD
Federico II University 24
Large-scale testing (Phase 3)Ended earlyNCT02410343
What this trial is testing

Study of TV-1106 in Growth Hormone-Deficient Adults

Who this might be right for
Growth Hormone Deficiency
Teva Branded Pharmaceutical Products R&D, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT01811576
What this trial is testing

Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Teva Branded Pharmaceutical Products R&D, Inc. 52
Not applicableStudy completedNCT01080755
What this trial is testing

Metabolic Endocrinology and Growth Hormone in Adults

Who this might be right for
Adult Growth Hormone Deficiency
Merck KGaA, Darmstadt, Germany 90
Not applicableStudy completedNCT03672617
What this trial is testing

Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy

Who this might be right for
Growth Hormone Deficiency in Children
Novo Nordisk A/S 321
Not applicableStudy completedNCT00774579
What this trial is testing

The Effect of Growth Hormone Replacement on Liver Fat

Who this might be right for
Growth Hormone, RecombinantFatty Liver
Imperial College London 30
Not applicableStudy completedNCT00711061
What this trial is testing

Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

Who this might be right for
Growth Hormone Deficiency
Children's Mercy Hospital Kansas City 24
Large-scale testing (Phase 3)Study completedNCT04615273
What this trial is testing

A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency

Who this might be right for
Growth Hormone DeficiencyEndocrine System DiseasesHormone Deficiency
Ascendis Pharma Endocrinology Division A/S 264
Next Page